Diclofenac (Voltaren, Voltaren Ophtha) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 23, 2026
Also sold as: Voltaren, Voltaren Ophtha, Pennsaid
Some Diclofenac products are in shortage in Canada (5 of 34 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 18, 2026.
An anti-inflammatory (NSAID) used to relieve pain and inflammation, such as from arthritis.
Products affected
5 / 34
In shortage since
Mar 27, 2023
Est. full return
Sep 18, 2026
Reports on file
126
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
DICLOFENAC
0.1% · SOLUTION · PHARMA STULLN INC.
DIN 02475065 · since Jul 22, 2026, est. end Aug 3, 2026 · Delay in shipping of the drug.
Active shortage
JAMP DICLOFENAC
0.1% · SOLUTION · JAMP PHARMA CORPORATION
DIN 02534525 · since Mar 12, 2026, est. end Sep 18, 2026 · Disruption of the manufacture of the drug.
Active shortage
PMS-DICLOFENAC
1.5% · SOLUTION · PHARMASCIENCE INC
DIN 02356783 · since ?, no end estimate · Disruption of the manufacture of the drug.
Active shortage
MINT-DICLOFENAC
0.1% · SOLUTION · MINT PHARMACEUTICALS INC
DIN 02475197 · since Mar 27, 2023, est. end Dec 31, 2025 · Disruption of the manufacture of the drug.
Active shortage
MINT-DICLOFENAC
0.1% · SOLUTION · MINT PHARMACEUTICALS INC
DIN 02475197 · since Mar 27, 2023, est. end Dec 31, 2025 · Disruption of the manufacture of the drug.
Active shortage
APO-DICLOFENAC OPHTHALMIC
0.1% · SOLUTION · APOTEX INC
DIN 02441020 · since Jul 11, 2023, no end estimate · Disruption of the manufacture of the drug.
Resolved
DICLOFENAC
0.1% · SOLUTION · PHARMA STULLN INC.
DIN 02475065 · ended Jun 15, 2026 · Delay in shipping of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Diclofenac is currently affected by 5 active shortage reports filed with Health Canada by PHARMA STULLN INC., JAMP PHARMA CORPORATION, PHARMASCIENCE INC, MINT PHARMACEUTICALS INC and 1 others.
The reported causes are: delay in shipping of the drug; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Diclofenac is classified under “ANTIINFLAMMATORY AGENTS” (ATC S01BC).
Recent changes
Jul 23, 2026
New report filed
Jul 10, 2026
Shortage resolved
Common questions
What is Diclofenac used for?
An anti-inflammatory (NSAID) used to relieve pain and inflammation, such as from arthritis.
When will Diclofenac be back in stock in Canada?
The latest manufacturer estimate is Sep 18, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Diclofenac in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.